Our study matched those of prior studies and also indicated that circ-MBOAT2 expression was upregulated in NSCLC patients, and that knocking down circ-MBOAT2 hampered proliferation of NSCLC cells, as well as EMT and blocked the immune escape of NSCLC cells. Here, MBOAT2 is linked to non-small cell lung carcinoma.